2型内漏腔内治疗效果的评价
该单中心队列纳入1998至2018年19例因2型内漏接受腔内治疗的患者(中位年龄76岁),即刻成功15例;作者认为长期临床复发常见,导致数例死亡并需开放手术。
要点
- 19例2型内漏腔内治疗患者,即刻成功15例(经动脉栓塞8例、直接瘤囊穿刺8例、联合3例)。
- 随访中5例需再次经腰栓塞、6例因复发需开放手术,6例死亡(2例与动脉瘤相关)。
核心结论
- 作者认为,在其经验中经腔内治疗的2型内漏长期临床复发似乎常见,导致数例死亡并需开放手术治疗。
研究设计与样本
- 单中心队列,纳入1998至2018年因2型内漏接受腔内技术治疗的患者,进行描述性分析。
主要发现
- 607例患者于1998至2018年接受腹主动脉瘤腔内治疗,期间发生145例2型内漏。
- 19例患者(中位年龄76岁)接受2型内漏腔内治疗,15例即刻成功(经动脉栓塞8例、直接瘤囊穿刺8例、联合手术3例)。
- 随访期间5例需再次经腰栓塞,6例因2型内漏复发需开放手术。
- 6例死亡,其中2例死因与动脉瘤相关。
关键数值与推荐
- 临床复发定义为动脉瘤囊持续增长,影像学复发定义为栓塞后CT扫描出现2型内漏。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endovascular abdominal aortic aneurysm repair (EVAR) is a safe and minimally invasive alternative to open surgical repair for infra renal aortic aneuvrysm. EVAR requires lifelong post-procedural surveillance. Endoleaks represent the main complication. Type II endoleaks (EL2) are the most frequent and tend to be indolent. Most practitioners do not treat in EL2 as long as they are associated with stable aneurysm diameter. European guidelines recommend treatment in case of aneurysm growth. Several techniques can be offered, such as transarterial embolization and translumbar embolization. This study reports the experience and results of a single center for EL2 endovascular treatment. The aim of this study was to determine more precisely the efficacity of embolization for type 2 endoleaks treatment. METHODS: A single center cohort of patients treated for EL2 with endovascular technique between 1998 and 2018 was formed to perform a descriptive analysis. Preoperative sizing, risk factors of endoleaks and intraoperative data were collected. Computed topography (CT) scans were regularly performed after EVAR to detect endoleak recurrence. Clinical recurrence was defined as the persistence of aneurysm sac growth and radiological recurrence was defined as the occurrence of EL2 on a post-embolization CT scan. Data related to reintervention, overall mortality and aneurysm related mortality were also collected. Kaplan-Meier survival analyses were used to determine the rates of reoperation-free survival and recurrence-free survival. RESULTS: Six hundred seven patients underwent an endovascular treatment for abdominal aorta aneurysm between 1998 and 2018. One hundred forty-five type 2 endoleaks occurred during this period. Nineteen patients (median age 76 years), underwent endovascular treatment for EL2, with immediate success on 15 patients (8 transarterial embolization, 8 direct sac puncture and 3 combined procedures). During follow-up, 5 patients required a new translumbar embolization and 6 required an open surgery for recurrence of the EL2. Six patients died, 2 of them of causes related to the aneurysm. At 59,6 months median follow-up, 53% of the patients presented a radiologic recurrence, with a sac growth of more than 5 mm since last procedure in 4 patients (24%). CONCLUSIONS: Long term clinical recurrence of type 2 endoleaks treated by endovascular procedures appear to be frequent in our experience, leading to several deaths and requiring open surgical treatment.
引用
- Dié Loucou J, Salomon du Mont L, Jazayeri A, et al. Evaluation of the Effectiveness of Endovascular Treatment of Type 2 Endoleaks. Ann Vasc Surg. 2022. PMID: 35878699. doi:10.1016/j.avsg.2022.06.099
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。